Issue 3/2018
Content (10 Articles)
Continued Interest and Controversy: Vitamin D in HIV
Evelyn Hsieh, Michael T. Yin
NAFLD and HIV: Do Sex, Race, and Ethnicity Explain HIV-Related Risk?
Subada Soti, Kathleen E. Corey, Jordan E. Lake, Kristine M. Erlandson
Factors Associated With Insulin Resistance in Adults With HIV Receiving Contemporary Antiretroviral Therapy: a Brief Update
Todd Hulgan
HIV and Cardiovascular Disease: Update on Clinical Events, Special Populations, and Novel Biomarkers
Kaku So-Armah, Matthew S. Freiberg
Challenges Facing a Rural Opioid Epidemic: Treatment and Prevention of HIV and Hepatitis C
Asher J. Schranz, Jessica Barrett, Christopher B. Hurt, Carlos Malvestutto, William C. Miller
Opioid Use Among Those Who Have Criminal Justice Experience: Harm Reduction Strategies to Lessen HIV Risk
Lauren Brinkley-Rubinstein, David Cloud, Ernest Drucker, Nickolas Zaller
The Policy-Driven HIV Epidemic Among Opioid Users in the Russian Federation
Robert Heimer
Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?
Katherine M. Rich, Joshua Bia, Frederick L. Altice, Judith Feinberg
Syringe Decriminalization Advocacy in Red States: Lessons from the North Carolina Harm Reduction Coalition
David H. Cloud, Tessie Castillo, Lauren Brinkley-Rubinstein, Manisha Dubey, Robert Childs
Network Research Experiences in New York and Eastern Europe: Lessons for the Southern US in Understanding HIV Transmission Dynamics
Samuel R. Friedman, Leslie Williams, April M. Young, Jennifer Teubl, Dimitrios Paraskevis, Evangelia Kostaki, Carl Latkin, Danielle German, Pedro Mateu-Gelabert, Honoria Guarino, Tetyana I. Vasylyeva, Britt Skaathun, John Schneider, Ania Korobchuk, Pavlo Smyrnov, Georgios Nikolopoulos